202 related articles for article (PubMed ID: 27779780)
1. Incidence and time trends of drug-induced parkinsonism: A 30-year population-based study.
Savica R; Grossardt BR; Bower JH; Ahlskog JE; Mielke MM; Rocca WA
Mov Disord; 2017 Feb; 32(2):227-234. PubMed ID: 27779780
[TBL] [Abstract][Full Text] [Related]
2. Time Trends in the Incidence of Parkinson Disease.
Savica R; Grossardt BR; Bower JH; Ahlskog JE; Rocca WA
JAMA Neurol; 2016 Aug; 73(8):981-9. PubMed ID: 27323276
[TBL] [Abstract][Full Text] [Related]
3. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990.
Bower JH; Maraganore DM; McDonnell SK; Rocca WA
Neurology; 1999 Apr; 52(6):1214-20. PubMed ID: 10214746
[TBL] [Abstract][Full Text] [Related]
4. Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism.
Savica R; Grossardt BR; Bower JH; Ahlskog JE; Rocca WA
JAMA Neurol; 2013 Jul; 70(7):859-66. PubMed ID: 23689920
[TBL] [Abstract][Full Text] [Related]
5. Time trends in the incidence of parkinsonism in Olmsted County, Minnesota.
Rocca WA; Bower JH; McDonnell SK; Peterson BJ; Maraganore DM
Neurology; 2001 Aug; 57(3):462-7. PubMed ID: 11502914
[TBL] [Abstract][Full Text] [Related]
6. Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex.
Marras C; Herrmann N; Anderson GM; Fischer HD; Wang X; Rochon PA
Am J Geriatr Pharmacother; 2012 Dec; 10(6):381-9. PubMed ID: 23217531
[TBL] [Abstract][Full Text] [Related]
7. Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study.
Savica R; Grossardt BR; Bower JH; Ahlskog JE; Boeve BF; Graff-Radford J; Rocca WA; Mielke MM
JAMA Neurol; 2017 Jul; 74(7):839-846. PubMed ID: 28505261
[TBL] [Abstract][Full Text] [Related]
8. Trends in the Incidence of Parkinson Disease in the General Population: The Rotterdam Study.
Darweesh SK; Koudstaal PJ; Stricker BH; Hofman A; Ikram MA
Am J Epidemiol; 2016 Jun; 183(11):1018-26. PubMed ID: 27188952
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced parkinsonism as a risk factor for Parkinson's disease: a historical cohort study in Olmsted County, Minnesota.
Chabolla DR; Maraganore DM; Ahlskog JE; O'Brien PC; Rocca WA
Mayo Clin Proc; 1998 Aug; 73(8):724-7. PubMed ID: 9703296
[TBL] [Abstract][Full Text] [Related]
10. Atypical antipsychotics and parkinsonism.
Rochon PA; Stukel TA; Sykora K; Gill S; Garfinkel S; Anderson GM; Normand SL; Mamdani M; Lee PE; Li P; Bronskill SE; Marras C; Gurwitz JH
Arch Intern Med; 2005 Sep; 165(16):1882-8. PubMed ID: 16157833
[TBL] [Abstract][Full Text] [Related]
11. Managing antipsychotic-induced parkinsonism.
Mamo DC; Sweet RA; Keshavan MS
Drug Saf; 1999 Mar; 20(3):269-75. PubMed ID: 10221855
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic medications and drug-induced movement disorders other than parkinsonism: a population-based cohort study in older adults.
Lee PE; Sykora K; Gill SS; Mamdani M; Marras C; Anderson G; Shulman KI; Stukel T; Normand SL; Rochon PA
J Am Geriatr Soc; 2005 Aug; 53(8):1374-9. PubMed ID: 16078964
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced parkinsonism in the aged. Recognition and prevention.
Gershanik OS
Drugs Aging; 1994 Aug; 5(2):127-32. PubMed ID: 7981484
[TBL] [Abstract][Full Text] [Related]
14. 40-Year Incidence of Early-Onset Parkinson's Disease in Southeast Minnesota.
Camerucci E; Mullan AF; Turcano P; Bower J; Piat C; Ahlskog JE; Savica R
J Parkinsons Dis; 2023; 13(6):893-898. PubMed ID: 37522219
[TBL] [Abstract][Full Text] [Related]
15. Early-Onset Parkinsonism and Early-Onset Parkinson's Disease: A Population-Based Study (2010-2015).
Camerucci E; Stang CD; Hajeb M; Turcano P; Mullan AF; Martin P; Ross OA; Bower JH; Mielke MM; Savica R
J Parkinsons Dis; 2021; 11(3):1197-1207. PubMed ID: 33720851
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and incidence of Parkinson's disease and drug-induced parkinsonism in Korea.
Han S; Kim S; Kim H; Shin HW; Na KS; Suh HS
BMC Public Health; 2019 Oct; 19(1):1328. PubMed ID: 31640652
[TBL] [Abstract][Full Text] [Related]
17. Effect of Antipsychotic Type and Dose Changes on Tardive Dyskinesia and Parkinsonism Severity in Patients With a Serious Mental Illness: The Curaçao Extrapyramidal Syndromes Study XII.
Mentzel CL; Bakker PR; van Os J; Drukker M; Matroos GE; Hoek HW; Tijssen MA; van Harten PN
J Clin Psychiatry; 2017 Mar; 78(3):e279-e285. PubMed ID: 28199071
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced parkinsonism: relationship to age at onset of schizophrenia.
Sandyk R; Kay SR
Funct Neurol; 1991; 6(2):151-7. PubMed ID: 1680777
[TBL] [Abstract][Full Text] [Related]
19. Survival and Progression in Synucleinopathy Phenotypes With Parkinsonism: A Population-Based Study.
Savica R; Turcano P; Bower JH; Ahlskog JE; Mielke MM
Mayo Clin Proc; 2019 Sep; 94(9):1825-1831. PubMed ID: 31405749
[TBL] [Abstract][Full Text] [Related]
20. Severe parkinsonism under treatment with antipsychotic drugs.
Druschky K; Bleich S; Grohmann R; Engel RR; Toto S; Neyazi A; Däubl B; Stübner S
Eur Arch Psychiatry Clin Neurosci; 2020 Feb; 270(1):35-47. PubMed ID: 31444566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
